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Objective: Early primary repair of tetralogy of Fallot has been routinely performed
at Children’s Hospital, Boston, since 1972. We evaluated the long-term outcome of
this treatment strategy including the influence of a transannular patch. 
Methods: Fifty-seven patients less than 24 months of age (median 8 months) under-
went primary repair of tetralogy of Fallot between January 1972 and December 1977.
Thirty-one patients had a transannular patch. Survival and freedom from reintervention
were determined by the Kaplan-Meier method with 95% confidence intervals. 
Results: There were 8 early deaths, and 1 patient died 24 years after initial repair.
Recent follow-up was obtained for 45 of the 49 long-term survivors (92%). Median
follow-up was 23.5 years. Ten patients underwent reintervention, 8 of whom under-
went relief of right ventricular outflow tract obstruction. Right ventricular outflow
tract obstruction occurred in 6 patients without a transannular patch and 2 with a
transannular patch (33% vs 6%, P = .04). One pulmonary valve replacement was
performed at another institution 20 years after the repair. Forty-one long-term sur-
vivors were in New York Heart Association class I and 4 were in class II. Actuarial
survival was 86% at 20 years (95% confidence intervals = 80%-92%). Freedom
from reintervention was 93% at 5 years (95% confidence intervals = 87%-99%) and
79% at 20 years (95% confidence intervals = 70%-86%). No significant differences
were found between patients with and without a transannular patch (survival, P =
.34; freedom from reintervention, P = .09, log-rank tests).
Conclusions: Long-term survival is excellent and the freedom from reintervention
is satisfactory after early primary repair of tetralogy of Fallot in the 1970s. Use of
a transannular patch does not reduce late survival and is associated with a lower
incidence of right ventricular outflow tract obstruction. 
Complete repair of tetralogy of Fallot (TOF) has been performed sincethe 1950s. A large number of long-term studies have documented sat-isfactory results 30 to 40 years after reparative surgery performed atan older age and often after initial palliative surgery.1-4 The conceptof early primary repair of TOF was introduced at Children’sHospital in Boston in 1972 by Castaneda and associates,5 but until
now few centers have had sufficient numbers of patients operated on at an early age
to allow for meaningful long-term follow-up.6-10 Controversy continues to surround
the design of the surgical procedure, particularly with respect to the importance of
residual pulmonary regurgitation.11,12 There is mounting concern that over the long
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term, free pulmonary regurgitation may lead to progressive
right-sided heart failure, reduced functional status, arrhyth-
mias, reoperations, and reduced life expectancy.13-15 Some
centers have reported high rates of reoperation to replace the
pulmonary valve in these patients.12,16 On the other hand,
residual right ventricular outflow tract (RVOT) obstruction
is also known to result in a high incidence of reoperation
and arrhythmias.11,12 The purpose of this study was to deter-
mine the long-term outcome after early primary repair of
TOF and to assess the impact of a transannular patch (TAP).
Patients and Methods
Patient Population
The study population consisted of the first cohort of patients to
undergo early primary repair of TOF at Children’s Hospital in
Boston. Between January 1972 and December 1977, 57 consecu-
tive patients (40 boys) 24 months of age or younger underwent
early primary repair of TOF and pulmonary stenosis. Median age
at surgery was 8 months (range 2 weeks–24 months). Mean weight
was 6.5 ± 2.6 kg (range 2.0-11.4 kg). Patients with prior aortopul-
monary shunts, pulmonary atresia, absent pulmonary valve, or
atrioventricular septal defects were excluded from the study.
Thirty-three (58%) patients had documented cyanotic spells before
the operation. Anatomic variations included a right-sided aortic
arch in 9 (15%), aortopulmonary window in 1, and an anomalous
origin of the left anterior descending artery from the right coronary
artery in 1 patient. Associated genetic anomalies included
DiGeorge syndrome, VACTERL syndrome,* and tracheo-
esophageal fistula in 1 patient each. Repair was performed with all
patients under deep hypothermic circulatory arrest during this era.5
An infundibular incision was used (longitudinal in 47 patients,
transverse in 10), and the ventricular septal defect was closed with
interrupted sutures working through the ventriculotomy. The deci-
sion regarding use of a TAP was made after assessing the pul-
monary valve anulus diameter. The right atrium was not opened.
The pulmonary valve anulus was divided and enlarged by means of
a TAP made of autologous untreated pericardium in 37 patients
(65%). The foramen ovale was deliberately left open.
Study Design and Data Collection
The design was a retrospective cohort study. All medical charts,
including most recent clinic notes, echocardiography, exercise test-
ing, and Holter reports, were reviewed. All patients not known to
be dead were sent an inquiry letter. For patients who did not
respond within 3 weeks, further attempts were made to locate and
interview, by telephone. To locate patients who could not other-
wise be found, we used a commercially based search company (US
search.com, Los Angeles, Calif). Information was sought regard-
ing the health status of each patient. Any relevant documentation
with respect to recent cardiovascular events or studies was
reviewed. Queries included in the questionnaire are listed in Table
1. This clinical investigation was approved by the Institutional
Review Board of Children’s Hospital, Boston.
Statistical Analysis
Actuarial survival and freedom from reintervention rates were deter-
mined by the Kaplan-Meier product-limit method with 95% confi-
dence intervals (CI) derived by Greenwood’s formula. Survival
curves were compared by the log-rank test.17 The Cox proportional-
hazards regression model18 was used to adjust for possible con-
founding and establish the variables independently associated with
each outcome with risk measured by the hazard ratio (HR) with 95%
CI. A forward stepwise selection procedure was used to derive the
final multivariate equations, with the following covariates entered
into the model: sex, age and weight at operation, year of operation,
need for emergency surgery, presence of a genetic syndrome, coro-
nary abnormality, and use of a TAP. Simple proportions including
early mortality and the incidence of RVOT obstruction between
patients with and without TAP were compared by the Fisher exact
test. Biostatistical analysis was performed by means of SAS (version
6.12, SAS Institute, Cary, NC) and SPSS (version 10.0, SPSS Inc,
Chicago, Ill) software packages.
Results
Follow-up
Cross-sectional follow-up between January 1999 and
December 2000 was achieved in 31 (63%) of the 49 long-term
survivors. Median follow-up was 23.5 years (range 12
months–27 years). Thirty-eight (78%) patients had at least 20
years of follow-up and 7 (14%) had 10 to 20 years of follow-
up. Four patients (8%) were lost to follow-up within 2 years
after initial repair of TOF.
Survival
Among the 57 patients, there were 8 (14%) early deaths, 6
of which occurred on the operative day. Six (16%) of the 37
patients with TAP died early compared with 2 (10%) of the
20 patients without TAP (P = .69, Fisher exact test). One
late death occurred 24 years after initial repair as a result of
a myocardial infarction documented at autopsy. Actuarial
TABLE 1. List of general health and cardiac questions
included in the questionnaire sent to patients
General health:
General well-being
Quality of life
Sports (if any)
Exercise capacity (most recent treadmill test)
Medication
Pregnancies (attempted, complications, successful)
Cardiac:
Any heart surgery since the initial operation?
Most recent chest x-ray film
Most recent echocardiogram
Most recent cardiac catheterization
Heart rhythm problems (most recent electrocardiogram or 
Holter test)
*Vertebral abnormalities, Anal atresia, Cardiac abnormalities,
Tracheoesophageal fistula and/or Esophageal atresia, Renal agenesis and
dysplasia, and Limb defects.
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survival was 86% at 20 years (CI = 80%-92%). There was
no difference in long-term survival between the TAP and
non-TAP groups (Figure 1, P = .34, log-rank test). Table 2
presents the results of the univariable and multivariable
analyses. Analysis by means of the Cox proportional haz-
ards model revealed that lower weight at surgery was an
independent risk factor for overall mortality (HR = 2.6, 95%
CI = 1.2-7.7, P = .02). None of the other covariates tested
were predictive of mortality (all P > .2).
Reintervention
Ten patients required a reintervention. Table 3 presents a
descriptive summary of the reinterventions. The most com-
mon indication was residual or recurrent RVOT obstruction,
which occurred in 8 patients. One patient who had a transan-
nular repair was seen at another institution after 20 years with
free pulmonary regurgitation, a dilated right ventricle, and
fatigue. A homograft pulmonary valve replacement was per-
formed, with slight improvement in symptoms. One patient
required a defibrillator for inducible ventricular tachycardia.
The patient with an anomalous anterior descending coronary
artery had incomplete relief of pulmonary stenosis at the time
of the primary repair. Because of the obligatory nature of his
reoperation, he was excluded from subsequent statistical
analysis of reinterventions. He underwent placement of a right
ventricular–pulmonary artery conduit 6 years after the original
procedure. Actuarial freedom from reintervention was 93% at
5 years (95% CI = 87%-99%) and 79% at 20 years (95% CI =
70%-86%). Although the freedom from reintervention was
longer for patients with a TAP than for those without a TAP,
the difference did not reach statistical significance (Figure 2,
P = .09, log-rank test). RVOT obstruction occurred in 6 of the
18 patients with non-TAP repair compared with 2 of 31 with
TAP (33% vs 6%, P = .04, Fisher exact test). Results of the
multivariable analysis indicated that both earlier year of oper-
ation (P = .01) and presence of a genetic syndrome (P = .02)
were independent risk factors for reintervention (Table 2).
To ensure that no bias was being introduced by including
patients with a transverse ventriculotomy into the non-TAP
group, an approach that is abandoned today, we performed a
separate analysis excluding the 10 patients who had this
approach. Reintervention rates were not different between the
TAP and non-TAP groups (P = .49, log-rank test), and free-
dom from reintervention was 100% (95% CI = 94%-100%) at
5 years and 84% at 20 years (95% CI = 73%-95%).
Late Functional Assessment: Exercise Tolerance,
Cardiovascular Status, Medications, Reproductive
Health
Forty-one (91%) of 45 patients having at least 10 years of fol-
low-up (median 23 years) reported or had documented excel-
lent exercise tolerance with no limitations to participation in
sports or heavy physical activity (New York Heart Association
class I). Four patients reported moderate exercise tolerance
(New York Heart Association class II). One patient was receiv-
ing digoxin. Of 11 female patients with follow-up, 3 reported
having uncomplicated pregnancies with a total of 5 children.
Rhythm
Thirty-four (76%) patients had documented normal sinus
rhythm according to an electrocardiogram obtained an aver-
age of 22.7 ± 3.8 years after the initial operation. Six
TABLE 2. Predictors of outcome
Univariable, Kaplan-Meier analysis Multivariable,* Cox proportional hazards analysis
Outcome Variable P value HR 95% CI P value
Overall mortality Sex .1 .43
Age at operation (mo) .09 .94
Lower weight at operation (kg) .007 2.6 1.2-7.7 .02
Need for emergency surgery .69 .75
Earlier year of operation .77 .8
Genetic syndrome .08 .22
Coronary abnormality .71 .74
TAP vs non-TAP .34 .37
Reintervention Sex .61 .5
Age at operation (mo) .35 .79
Lower weight at operation (kg) .49 .62
Need for emergency surgery .53 .74
Earlier year of operation .006 2.0 1.3-2.8 .01
Genetic syndrome <.001 8.3 2.5-35.6 .02
Coronary abnormality .07 .13
TAP vs non-TAP .09 .2
HR, Hazard ratio; CI, confidence interval; TAP, transannular patch.
*Results of multivariable analysis for overall mortality (as shown) are identical to the results obtained for early mortality.
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patients had Holter monitor tests obtained 10 to 19 years
after repair. One patient had inducible ventricular tachycar-
dia and received an automatic implantable cardioverter-
defibrillator; others were without notable findings.
Recent Echocardiograms
Thirty-nine (87%) patients had an echocardiographic study
performed 19.3 ± 4.3 years after repair. There were no resid-
ual ventricular septal defects (Figure 3).
Recent Catheterizations
Thirty-five (71%) of the 49 long-term survivors had a car-
diac catheterization study, 10 of which were performed after
1990. The indications for all of these catheter studies were
echocardiographic findings of either high RVOT gradients
or right ventricular dilation. Three patients needed a reinter-
vention on the basis of the findings at catheterization.
Discussion
Current surgical management of TOF at Children’s Hospital,
Boston, involves early primary repair within the first 3 months
of life. This approach has yielded excellent midterm results
through avoidance of long-standing cyanosis, palliative shunt
procedures, and right ventricular pressure overload19 but has,
at least in some studies, resulted in a larger proportion of
infants receiving a transannular repair.3,20 The late outcome of
early repair remains uncertain, however, because most reports
describe only limited follow-up.8-10 Our study substantiates
the safety of transannular repair at an early age and confirms
excellent long-term survival and freedom from reintervention
with early primary repair.
Survival
The need for a TAP reflects the severity of the RVOT
obstruction at the annular level. Consequently, patients in
whom a TAP was used were at the more severe end of the
morphologic spectrum. However, in this study, long-term
survival of patients after transannular repair was equivalent
to that of patients with anulus-sparing repairs, implying that
the use of a TAP resulted in neutralization of this risk factor.
Several large studies involving patients undergoing repair at
an older age than in the present investigation have shown
similar findings. In a series of 106 patients with 25 years of
follow-up after correction of TOF, Lillehei and associates21
reported no pulmonary valve replacement or right ventricu-
lar failure. In a retrospective study with a minimum follow-
up period of 29 years, Murphy and colleagues1 showed that
the need for a TAP was not associated with reduced 30-year
survival. Similarly, Meijboom and coworkers22 found no
difference in long-term survival in a cohort of patients, half
of whom had a TAP, 14.7 years after TOF repair. Our data
extend these observations and confirm that the compensato-
ry responses to chronic right ventricular overload can be
adequate for at least 25 years. In contrast, a recent study by
Nollert and colleagues2 showed that transannular repair was
associated with reduced long-term survival, although these
investigators found that any patch placed in the RVOT was
associated with poorer long-term survival. However, many
technical factors in addition to use of a TAP might influence
late outcome. These factors include the length of the ven-
triculotomy, width of the patch, number of coronary arteries
divided, preservation of the moderator band, and preserva-
tion of tricuspid valve function through careful attention to
Figure 1. Kaplan-Meier estimated overall survival according to type of repair (P = .34, log-rank test). Error bars
denote lower 95% confidence intervals. Numbers of patients in follow-up are shown in parentheses in italics
(TAP) and boldface (non-TAP).
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papillary muscles, chords, and leaflets during patch place-
ment on the ventricular septal defect. Distortion and steno-
sis of the pulmonary arteries, as well as elevation of pul-
monary resistance by preliminary shunts, are important
additional factors when a 2-stage rather than a primary
repair is undertaken.
Freedom From Reintervention
Several investigators have implicated transannular patching
as a risk factor for reintervention.12,13,16,23 A large body of
experimental work has been published demonstrating the
deleterious effects of chronic pulmonary regurgitation on
right ventricular function, right ventricular volume, and
Figure 2. Kaplan-Meier estimated freedom from reintervention according to type of repair (P = .09, log-rank test).
Error bars denote lower 95% confidence intervals. Numbers of patients in follow-up are shown parentheses in
italics (TAP) and boldface (non-TAP).
TABLE 3. Clinical course of the 10 patients who had reintervention
Initial procedure: Indication for Time interval between
Patient TOF repair including: reintervention Reintervention initial operation and reoperation (y)
1 TAP Patch aneurysm, RVOTO Resection of aneurysm and 20
muscle bundles 
2 TAP Dilated RV, fatigue Pulmonary valve replacement 20
with homograft, pacemaker
3 TAP VT AICD 19 
4 Primary closure of transverse RVOTO, DCRV Resection of muscle bundles, 18
infundibulotomy patch closure
5 Non-TAP and aortopulmonary RVOTO Resection of supravalvular membrane, 14
window patch repair pulmonary valvulectomy, PA plasty
6 TAP Distal main PA stenosis PA balloon dilation 12
7 Non-TAP (anomalous origin RVOTO RV-PA conduit 6
of LAD)
8 Primary closure of transverse RVOTO, residual VSD VSD closure, patch closure 4 
infundibulotomy
9 Patch closure of transverse Patch aneurysm, RVOTO Resection of aneurysm, TAP 1
infundibulotomy
10 Primary closure of transverse RVOTO TAP 0.5 
infundibulotomy
TOF, Tetralogy of Fallot; TAP, transannular patch; RVOTO, right ventricular outflow tract obstruction; RV, right ventricle; VT, ventricular tachycardia; AICD,
automatic implantable cardioverter-defibrillator; DCRV, double-chambered right ventricle; PA, pulmonary artery; LAD, left anterior descending coronary
artery.
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exercise performance.24,25 Several authors have also advo-
cated correction of chronic pulmonary regurgitation with
insertion of a valve in the RVOT, describing large series of
patients undergoing this procedure.12,13,16,23 In most series,
however, indications have been relatively ill-defined.
Inferences are further complicated by the poor correlation
between right ventricular function and exercise perfor-
mance.24 In the present study, only 1 patient underwent pul-
monary valve replacement, with slight improvement in
symptoms.
The most common indication for reintervention in our
study was residual or recurrent RVOT obstruction (8/10).
This is in marked contrast to a recent study of 60 patients
who underwent reoperation after previous TOF repair, in
which pulmonary regurgitation was the primary indication
for reoperation in 23 patients.23 A recent study of the man-
agement of TOF showed that although more patients in the
first year of life had a TAP, this did not result in an increased
risk for reoperation.3 Our study showed no significant dif-
ference in need for reintervention between patients with or
without a TAP, although the incidence of RVOT obstruction
was significantly lower in those who had a TAP. Our long-
standing institutional philosophy, which is based on the evi-
dence that residual right ventricular hypertension is a risk
factor for late death, has been to eliminate aggressively
important gradients across the RVOT, especially in the pres-
ence of pulmonary regurgitation. Finally, the present inves-
tigation does not show impairment in quality of life or exer-
cise capacity, despite the presence of at least moderate
pulmonary regurgitation, in patients with a TAP.
Limitations of the Study
The indications for a transannular repair versus preservation
of the pulmonary valve in an infant with TOF can only be
identified conclusively in a prospective randomized study.
Because long-term results are excellent, a study with ade-
quate power is unlikely to be conducted. Exercise testing
was not done in our study, and the questionnaire relied, in
part, on subjective data from the patient. Subtle changes in
quality of life were not ascertained, and right ventricular
function per se was not studied. In addition, postoperative
right ventricular/left ventricular pressure ratios were not
uniformly documented. Nevertheless, the long-term results
after early primary repair of TOF have been satisfactory.
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Discussion
Dr Roger B. B. Mee (Cleveland, Ohio). Primary repair of
cyanotic TOF is inherently hazardous for basic physiologic rea-
sons. When the ventricular septal defect is closed, the right ventri-
cle is immediately volume loaded. In addition, the right side of the
heart is also insulted by suturing of the septal patch, ventriculoto-
my, and/or muscle resection, and it is further volume loaded from
various degrees of pulmonary incompetence and sometimes tricus-
pid valve incompetence. Cardiopulmonary bypass and myocardial
ischemia are further insults. Therefore, in repair of cyanotic TOF,
the heart is being asked to do a lot more after it has been injured. 
A shunt also volume loads acutely but in two well-connected
ventricles in a noninsulted heart. This is all old knowledge and it
cannot be changed by wishful thinking. 
The median follow-up potential in this group of patients is
about 26 years, and yet your median follow-up is actually only 171⁄2
years. Furthermore, you were unable to trace 10 of the survivors. I
do not think it can be assumed that the 10 survivors fared exactly
the same as the ones that had some recorded follow-up.
This was an excellent opportunity to look carefully at the very
concept that Boston has been promoting, namely, early primary
repair of TOF. Ascribing New York Heart Association class from a
questionnaire is notoriously subjective in children who have had
surgery for congenital heart disease.
The manuscript’s statement that early primary repair (median
age 8 months) is safe is not supported by the 14% mortality (17%
for TAP) in that era, in very good hands. At exactly the same time,
in Adelaide, Australia, in the hands of D’Arcy Sutherland, the
annual mortality for TOF repair never exceeded 5%. The policy of
repair in those days was to operate sometime before school age in
patients, some of whom had received a shunt. Therefore, I think to
say that this was safe is not true. Although early primary repair is
safe today, in the presence of much improved anesthesia, perfu-
sion, myocardial protection, and postoperative care, for basic phys-
iologic reasons it probably remains more hazardous for severely
cyanotic patients than shunting followed by repair by the age of
about 12 months.
What worries me with this paper is that so little information is
given about the right ventricles of these patients, and that is vital
information. A huge amount of temporal and objective data is
missing. Potentially this is a very important group of patients
because they were operated on in that era with a bold new policy,
and I would like to see full, up-to-date follow-up and objective data
from echocardiograms and exercise testing. You did not obtain
exercise tests in any of these patients, and only about 26 had an
electrocardiogram, in most cases many years ago. In terms of find-
ing out whether the patients are alive or dead, this question was last
asked somewhere between 20 and 2 years ago, in 39 of the 49
patients initially surviving the operation.
This is a most precious cohort of patients. It would be tremen-
dously valuable to our understanding of surgery for TOF to trace
all 49 initial survivors and seek up-to-date echocardiography, elec-
trophysiology, and metabolic stress testing.
Dr Bacha. Thank you for your comments, Dr Mee. 
I will first answer you question about whether it is safe to do an
early repair in cyanotic newborns. I respectfully disagree with your
statement regarding shunting versus complete repair. Repair in a
neonate allows you to almost completely avoid resecting muscle
from the infundibulum. The rate of TAP use in the neonatal age is
no greater, as shown by the combined study from the University of
Alabama at Birmingham and Boston in the mid-1980s. Therefore,
the pathophysiology of a child who has had repair of TOF is actu-
ally more benign than that of a newborn who has received a shunt. 
Regarding the patients who were lost to follow-up, obviously
this is a retrospective study, and we are not pretending that it is
more than that. The difficulties of identifying patients 20 years
after the initial repair are widely known. However, the median fol-
low-up remains 17.5 years and, therefore, the statistical analysis
should be valid. 
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large. We are also repairing TOF through a right ventriculotomy,
but this ventriculotomy is very limited.
The defenders of the right atrial approach postulate that they do
no ventriculotomy. I would like to ask what the difference is
between a ventriculotomy and ventriculectomy. When you resect
the parietal band, you do a ventriculectomy. Therefore, the no ven-
triculotomy rule is questionable. 
It is clear that in the youngest group of patients with TOF, who
are very sick, a wider volume must be resected to create the space
needed on the infundibulum. I suspect that sometimes it is neces-
sary to go into the septum. By contrast, the ventriculotomy
approach allows a minimal resection on the parietal band and
sometimes no resection. Particularly in neonates, we make no inci-
sion in the parietal band in good number of patients, and we sim-
ply correct the native abnormality, that is, the anterior displace-
ment of the septum. 
My question is this: Is there associated pulmonary branch
stenosis in your series? 
Dr Bacha. Yes. Some pulmonary branch stenoses were seen.
They were included in the RVOT obstructions.
The conclusion of our paper dealt with whether it is safe to use
a TAP when needed. Most of the reoperations that we were able to
document were done for RVOT obstruction. In trying to give our
patients the best quality of life and the lowest likelihood for reop-
eration, each surgeon must decide whether a TAP is appropriate or
not. If use of a TAP will offer the patient equal survival and a bet-
ter quality of life than a repair without a TAP, with the associated
risk of residual obstruction, then the TAP is the proper course.
I agree with your comments about the sophisticated right ven-
tricular studies. We did not study right ventricular function per se.
We did not use exercise testing, as has been done in other studies,
and obviously those tests could be done in a future study. 
Dr Francois Lacour-Gayet (Paris, France). We have similar
experience at Marie-Lannelongue Hospital with the long-term results
of TAP, although we have observed another cause for reoperation rep-
resented by patients with recurrent pulmonary branch stenosis.
My major comment concerns the point that you made in this
paper: a right ventriculotomy is not responsible for important right
ventricular dysfunction. I suspect that in your series, with opera-
tions performed early in 1972, the ventriculotomies were quite
